MS News that Caught My Eye Last Week: Vumerity Approval, Low Antibody Levels in MS Patients, GA Depot Trial, Tecfidera Study – Multiple Sclerosis News Today

0
656
MS News that Caught My Eye Last Week: Vumerity Approval, Low Antibody Levels in MS Patients, GA Depot Trial, Tecfidera Study – Multiple Sclerosis News Today

Ed Tobias highlights MS news stories from the past week, including FDA approval for disease-modifying therapy Vumerity for secondary progressive MS.
Read More

LEAVE A REPLY

Please enter your comment!
Please enter your name here